Highly potent antimicrobial peptides from N-terminal membrane-binding region of E. coli MreB

Area of Science:

• Microbiology
• Biochemistry
• Drug Discovery

Background:

• Antimicrobial resistance is a growing global health threat, diminishing the effectiveness of conventional antibiotics.
• Antimicrobial peptides (AMPs) are a promising alternative, often functioning by disrupting microbial cell membranes.
• Bacterial membrane-binding protein domains offer a novel source for developing self-like antimicrobial sequences.

Purpose of the Study:

• To investigate the potential of membrane-binding domains from microbial proteins as a source for next-generation antimicrobials.
• To design and synthesize peptide analogs based on the E. coli MreB protein's membrane-binding region.
• To evaluate the antimicrobial activity and mechanism of action of these novel peptides.

Main Methods:

• Selection of a 9-residue membrane-binding region from the E. coli MreB protein.
• Synthesis of peptide analogs, including C-terminal amidation and N-terminal acetylation.
• Further modification by N-terminal tryptophan extension.
• Assessment of broad-spectrum antimicrobial activity against Gram-negative bacteria, Gram-positive bacteria, and fungi.
• Mechanism of action studies using lipid-binding assays and electron microscopy.

Main Results:

• The 9-residue peptide and its acetylated analog exhibited broad-spectrum antimicrobial activity.
• N-terminal tryptophan extension significantly enhanced peptide efficacy, with lethal concentrations ≤10 μM.
• Tryptophan-extended peptides achieved complete killing of Candida albicans and resistant strains of Staphylococcus aureus (MRSA) at 5 μM.
• Studies indicated that the peptides kill microbes by disrupting their cell membranes.

Conclusions:

• Peptides derived from bacterial membrane-binding domains can be developed into potent, broad-spectrum antimicrobials.
• N-terminal tryptophan extension is a strategy to significantly boost antimicrobial peptide activity.
• Membrane disruption is the primary mechanism of action for these novel antimicrobial peptides, offering a potential solution to combat antimicrobial resistance.